We all know that the single greatest way to convert interest into sales is to build trust between your company and your customer. But establishing that trust can be more difficult than it initially seems. What are the best strategies to build trust and increase sales? There are a lot of different pieces to the trust puzzle, but most of them can be categorized into the following 3 main ideas: be authentic, be uncompromisingly scrupulous in how you deal with your customers, and take web security and the privacy of your customers seriously. http://youtu.be/QyyJlgGUbQI
EUROPEAN MICROWAVE WEEK - Peregrine Semiconductor Corp. (NASDAQ: PSMI), founder of RF SOI (silicon on insulator) and pioneer of advanced RF solutions, announces the expansion of its integrated product portfolio into DC and X-band frequencies. Today, Peregrine introduces two new integrated products–a True DC switch and an X-band core chip. Built on Peregrine's UltraCMOS® technology, both products integrate RF, digital and analog components onto a single chip. While integration has traditionally offered high-volume markets the benefit of lower cost, Peregrine uses intelligent integration to offer performance advantages in high-performance markets. Peregrine's integrated products offer benefits such as configurability, flexibility, reliability, repeatability, ease-of-use, a reduced form factor and enhanced performance.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7311051-peregrine-semiconductor-expands-integrated-product-portfolio/
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
John Dewar & Sons Ltd., one of the most respected names in the world of Scotch whisky, today announced plans to release a range of new expressions and never-before-released single malts – the hidden gems of its single malt portfolio. This bold move, unprecedented in recent years, will introduce a treasure trove of top-shelf whiskies to consumers around the world.
The distinguished drams of ABERFELDY®, AULTMORE®, CRAIGELLACHIE®, THE DEVERON® and ROYAL BRACKLA® are launched under the title of the “Last Great Malts,” each with a compelling story and character.
For generations, these distinctive whiskies have been distilled and left to mature undisturbed in oak casks. Now, at last, whisky aficionados the world over will be able to taste the single malts from these distilleries in their authentic form.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762539-Last-Great-Malts-Scotch-Whisky/
